...
首页> 外文期刊>Therapeutic advances in gastroenterology. >Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort
【24h】

Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort

机译:临床简单憩室疾病症状内憩室疾病的憩室临床评分的开发与验证急性憩室群体

获取原文

摘要

Background: Following an attack of acute diverticulitis (AD), many patients continue to suffer from a complex of symptoms, titled ‘symptomatic uncomplicated diverticular disease (SUDD)’. To date, there is no validated clinical score for standardized assessment of patients with SUDD, thereby hampering the interpretation of observational studies and the conductance of clinical trials. We aimed to develop a validated SUDD clinical score. Methods: Data from previous prospective study of patients after AD was used to devise the score’s first version. Validation was first performed using a focus group of patients after AD SUDD who underwent a structured cognitive personal interview. Thereafter, the diverticular clinical score (DICS) was applied for a second validation cohort. DICS scores of validation cohort were compared with physicians’ global assessment for disease severity and inflammatory markers. Results: In DICS second validation using 48 patients prospectively recruited after AD SUDD, a correlation matrix demonstrated strong correlation between total questionnaire’s score and the presence of elevated inflammatory markers ( ρ?=?0.84). Mean score in patients with elevated inflammatory markers compared with those without inflammation was 17.8 versus 6.2, respectively, p? Conclusions: Patients suffering from post-AD SUDD exhibit a wide range of symptoms. The newly developed DICS accurately and reproducibly quantitates SUDD-related symptom severity. The DICS may prove useful for monitoring SUDD in clinical practice and in research settings, as well as facilitating patient stratification and therapeutic decisions.
机译:背景:在急性憩室炎(AD)发作后,许多患者继续患有症状的复杂性,标题为“症状简单的憩室疾病(SUDD)”。迄今为止,没有验证的苏达患者标准化评估临床评分,从而阻碍了对观察性研究的解释和临床试验的指导。我们旨在制定经过验证的苏达特临床分数。方法:广告后以前的患者前瞻性研究的数据用于设计得分的第一个版本。验证首先在广告苏达德经历了结构性认知个人面试后首次使用患者焦点组进行。此后,施用憩室临床评分(DICS)用于第二次验证队列。 DICS评分验证队列与医生的全球疾病严重程度和炎症标志物的全球评估进行了比较。结果:在DICS第二次验证中使用48名患者在AD SUDD后令人医历,相关矩阵在总调查素分数和炎症标记升高的存在之间表现出强烈的相关性(ρ?= 0.84)。与没有炎症的炎症标志物升高的患者的平均得分为17.8,分别为6.2,p?结论:患有发后苏达特的患者表现出广泛的症状。新开发的DIC准确且可重复地定量毒品相关的症状严重程度。 DICS可以证明在临床实践和研究环境中监测SUDD,以及促进患者分层和治疗决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号